Note 14 - Nordic Bioscience (Detail) (USD $)	0 Months Ended	1 Months Ended
Aug. 30, 2012	Oct. 31, 2011	Sep. 30, 2012
Payments to Acquire Equity Method Investments	$ 50,000	$ 100,000
Equity Method Investments			56,000
Carrying Value of Analogs Contributed to Investee			6,000
Nordic Bioscience [Member]
Payments to Acquire Equity Method Investments	$ 950,000	$ 1,000,000
Joint Development Vehicle [Member]
Equity Method Investment, Ownership Percentage		50.00%

The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Paragraph 18

-Subparagraph f

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 18

-Paragraph 20

-Subparagraph a (1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Name:	us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant